UPS Healthcare Accelerates Cold Chain Capabilities

Rhea-AI Summary

UPS is enhancing its specialty pharmaceutical services with the launch of UPS Cold Chain Solutions, offering comprehensive temperature-controlled logistics to meet growing demand in the pharmaceutical and medical device sectors.

Key initiatives include the expansion of cold chain storage and transportation capabilities across Europe, with 390,000 square feet dedicated to biologics, and the introduction of customizable packaging solutions. The cold chain market is expected to grow significantly, driven by an increase in biologically derived drug development.

Positive

• Expansion of UPS Cold Chain Solutions to enhance temperature-controlled logistics for pharmaceuticals.
• Establishment of 390,000 square feet of cold chain storage for biologics ranging from 2°C to -80°C.
• Significant expected growth in cold chain market by 24% by 2024.

Negative

• None.

ATLANTA, May 24, 2021 (GLOBE NEWSWIRE) --

• UPS Cold Chain Solutions brings full suite of end-to-end cold chain capabilities to customers worldwide

UPS (NYSE: UPS) is expanding its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new and expanded global facilities providing complete, end-to-end temperature-controlled logistics.

“Our customers have been taking advantage of our cold chain capabilities for years, but the pandemic caused UPS to move even faster to enhance an integrated set of cold chain solutions to support the future of the pharmaceutical and medical device industry,” said Wes Wheeler, UPS Healthcare president. “UPS’s near-perfect, on-time delivery of the COVID-19 vaccine proves how effectively and efficiently our network handles biologically derived drugs, even at extreme temperatures.”

Chronic and life-threatening diseases, including cancers, respiratory, autoimmune and cardiovascular conditions, are the fastest growing disease categories in the world, creating a rapid acceleration in the development of biologically derived, temperature-controlled drugs and therapies. According to the Biopharma Cold Chain Sourcebook, cold chain trends show 48 percent growth between 2018 and 2024 for drugs that require at least 2 to 8 degrees Celsius storage and shipping. Additionally, the overall market for cold chain services (packaging, transportation and data services) is expected to significantly accelerate growth over the next three years, growing by 24 percent by 2024, after posting a 10 percent increase from 2019 to 2020.

“The future of the healthcare and specialty pharmaceutical industries will increasingly rely on robust cold chain networks to safely deliver temperature-controlled drugs and therapies to customers,” said Kate Gutmann, UPS chief sales and solutions officer and SVP, UPS Global Healthcare. “The continued evolution of our cold chain offerings ensures UPS is ready for the future and can continue to provide long-term value for our healthcare customers.”

Managing temperature excursion end-to-end
UPS Cold Chain Solutions is purpose-built to provide pharmaceutical companies, healthcare providers and laboratories a full, end-to-end cold chain service offering, including storage and distribution, transportation, visibility, and quality assurance capabilities to meet their complex demands for critical products around the world.

As part of a continued, aggressive strategy to build sophisticated capabilities in cold chain logistics, UPS Healthcare is expanding and augmenting its temperature-controlled products and services, including:

• Cold chain GMP storage capacities – roughly 390,000 square feet of coolers and freezers installed at UPS facilities to support the storage of biologics ranging from 2 degrees Celsius to as low as minus-80 degrees Celsius
• Packaging customization – recommendations for specific temperature-controlled packaging options to minimize total cost while ensuring safe and efficient transportation of products
• UPS European cold chain ground network expansion – adding more ground transportation fleets, better connection between gateways and teams of experts to create customizable solutions that fit our customers’ needs
• Transportation efficiencies – four flexible, temperature-regulated service options via air or ocean freight that can be configured to meet the needs of the pharmaceutical packaging and help keep customer costs down
• Precise monitoring with UPS® Premier technology – protocols to provide pinpoint visibility into covered pallets, boxes, trailers and packages within 10 feet of their location anywhere in the UPS network
• Facility updates – construction of two new GDP-compliant, healthcare-licensed distribution facilities in Italy and Australia, as well expansions and cold chain retrofit projects to facilities in The Netherlands, Czechia, Poland, Hungary and the U.S.

“UPS sets a high bar for excellence in cold chain delivery and logistics, and these current and future investments in innovative solutions will ensure we keep pushing the bar higher,” Wheeler said. “For our customers, we will remain focused on delivering on our commitment to ‘Quality Focused. Patient Driven.’”

You can learn more about UPS Cold Chain Solutions and other UPS Healthcare initiatives by visiting: www.ups.com/healthcare.

About UPS Healthcare

UPS Healthcare has 11 million square feet of GMP- and GDP-compliant healthcare distribution space in 128 facilities in 32 countries. UPS Healthcare services include: inventory management, temperature-controlled packaging and shipping, storage and fulfillment of medical devices, labs and clinical trial logistics. UPS Healthcare’s global infrastructure, its newest UPS Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today’s complex logistics demands for the pharmaceutical, medical device and laboratory diagnostic industries.

FAQ

What is UPS Cold Chain Solutions?

UPS Cold Chain Solutions is a comprehensive suite of temperature-controlled logistics services designed to support the pharmaceutical and medical device industries.

What are the new facilities being constructed by UPS for cold chain solutions?

UPS is constructing two new GDP-compliant healthcare-licensed distribution facilities in Italy and Australia to enhance its cold chain capabilities.

How much cold chain storage capacity is UPS adding?

UPS is adding roughly 390,000 square feet of cold chain storage to support the logistics of biologics.

What growth is expected in the cold chain market according to UPS?

The cold chain market is expected to grow by 24% by 2024, driven by increased demand for temperature-controlled drugs.

What temperature range can UPS's cold chain solutions handle?

UPS's cold chain solutions can handle temperatures ranging from 2°C to as low as -80°C for biologics.